CUOMO, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 5.124
NA - Nord America 5.025
AS - Asia 3.370
SA - Sud America 784
AF - Africa 236
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.584
Nazione #
US - Stati Uniti d'America 4.883
IT - Italia 1.410
SG - Singapore 1.127
RU - Federazione Russa 1.048
GB - Regno Unito 937
CN - Cina 933
BR - Brasile 621
IE - Irlanda 536
VN - Vietnam 371
HK - Hong Kong 266
FR - Francia 252
SE - Svezia 232
KR - Corea 182
DE - Germania 178
IN - India 145
UA - Ucraina 123
FI - Finlandia 93
ZA - Sudafrica 92
CA - Canada 77
AR - Argentina 69
NL - Olanda 66
TR - Turchia 65
MX - Messico 47
KE - Kenya 46
BD - Bangladesh 45
ES - Italia 45
PL - Polonia 40
AU - Australia 35
IQ - Iraq 31
JP - Giappone 31
AT - Austria 30
NG - Nigeria 25
CI - Costa d'Avorio 22
EC - Ecuador 22
CH - Svizzera 19
ID - Indonesia 19
PE - Perù 19
VE - Venezuela 18
PH - Filippine 16
PK - Pakistan 16
SA - Arabia Saudita 14
MY - Malesia 13
GR - Grecia 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
HU - Ungheria 11
CL - Cile 10
CO - Colombia 10
EG - Egitto 10
IR - Iran 10
PT - Portogallo 10
DK - Danimarca 9
MA - Marocco 9
TH - Thailandia 9
DZ - Algeria 8
PY - Paraguay 8
IM - Isola di Man 7
RO - Romania 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
ET - Etiopia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
UY - Uruguay 4
BF - Burkina Faso 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KW - Kuwait 3
MD - Moldavia 3
NO - Norvegia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 14.566
Città #
Southend 771
Dallas 727
Singapore 541
Dublin 527
Ashburn 391
Fairfield 357
Santa Clara 350
Moscow 334
Houston 265
Hefei 263
Hong Kong 246
Beijing 238
Siena 226
Chandler 190
San Jose 189
Seoul 174
Florence 160
Woodbridge 158
Wilmington 140
Milan 130
Seattle 118
Cambridge 115
Council Bluffs 105
Ho Chi Minh City 102
Jacksonville 102
Rome 93
The Dalles 93
Los Angeles 80
Princeton 78
Lauterbourg 75
Johannesburg 73
Dong Ket 71
Hanoi 69
New York 68
São Paulo 65
Ann Arbor 63
Helsinki 56
Munich 48
Bengaluru 41
Redondo Beach 41
Nairobi 34
Orem 34
Nanjing 33
Rio de Janeiro 33
Buffalo 32
San Diego 31
San Mateo 29
Boardman 25
London 25
Warsaw 25
Bologna 24
Chennai 24
Málaga 24
Nuremberg 24
Washington 24
Abuja 23
Brescia 23
Abidjan 22
Brooklyn 21
Sanliurfa 21
Chicago 20
Cinisello Balsamo 20
Lappeenranta 20
Naples 20
San Francisco 20
Tokyo 20
Prato 19
Amsterdam 18
Da Nang 18
Manchester 18
Montreal 18
Mumbai 17
Turin 17
Columbus 16
Trento 16
Vienna 16
Campinas 15
Frankfurt am Main 15
Lima 15
Paris 15
Cape Town 14
Dhaka 14
Stockholm 14
Tianjin 14
Denver 13
Livorno 13
Mexico City 13
Belo Horizonte 12
Boston 12
Norwalk 12
Shanghai 12
Sydney 12
Tashkent 12
Toronto 12
Guangzhou 11
Katwijk 11
Padova 11
Palermo 11
Turku 11
Biên Hòa 10
Totale 9.061
Nome #
Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use 567
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 521
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE 405
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 400
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 355
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 302
Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms 289
Drug safety evaluation of aripiprazole in bipolar disorder 258
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 256
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 240
Advances in treatment for postpartum major depressive disorder 237
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 217
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 206
Does higher severity really correlate with a worse quality of life in obsessive-compulsive disorder? A meta-regression 204
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 204
Prevalence, chronicity, burden and borders of bipolar disorder 198
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope? 197
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 196
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 194
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 192
Internet use by older adults with bipolar disorder: international survey results 189
The neural bases of social cognition in major depressive disorder: a review [La cognizione sociale nel disturbo depressivo maggiore: Una rassegna sulle basi neurali] 187
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 187
Perfenazina, amitriptilina e perfenazina-amitriptilina: Ruolo nella pratica clinica [Perphenazine, amitriptyline and perphenazine-amitriptyline: Role in clinical practice] 186
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 185
On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward 183
Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice 181
Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans 181
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 179
Accuracy of self-assessment of real-life functioning in schizophrenia 179
Exploring treatment strategies for mood stabilization in patients with major depressive disorder and mixed features 175
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 174
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 174
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward 171
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: Pharmacology and clinical practice 171
The impact of COVID-19 pandemic in patients with a diagnosis of Oral Lichen Planus: Pain perception and psychological profile analysis 163
Psychological interventions for post-traumatic stress disorder in women survivors of intimate partner violence: A systematic review and meta-analysis 156
Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations 153
Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis 151
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting 150
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 147
La responsabilità dello psichiatra [Duties and liabilities for psychiatrists] 146
Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity? 145
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 145
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 144
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 143
COVID-19 Diary from a Psychiatry Department in Italy 143
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder 140
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study 138
Treating major depressive disorder with mixed features 136
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel 136
null 134
Practical guidance for prescribing trazodone extended-release in major depression 132
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 126
QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes 124
Lamotrigine in bipolar disorder: preventing depression to treat the disease 124
Worldwide prevalence of obsessive-compulsive symptoms during the COVID-19 pandemic: A systematic review and meta-analysis 122
Association between polarity of first episode and solar insolation in bipolar I disorder 122
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study 121
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 118
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder 115
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis 114
Medico-legal implications of mobbing: a case law [Riflessioni medico-legali su un caso giudiziario di mobbing] 112
Insights into the Incidence, Course, and Management of Lithium-Induced Hypothyroidism in Real-World Psychiatric Practice in Italy 111
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 111
Erratum: Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations (BMC Medicine (2020) 18 (215) DOI: 10.1186/s12916-020-01685-9) 111
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians 108
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice 106
Personalized treatment of depression phenotypes: Role of trazodone in depression with insomnia 106
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 105
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder 105
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release 104
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 100
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD) 100
Investigating the Relationship between Autistic Traits, Ruminative Thinking, and Suicidality in a Clinical Sample of Subjects with Bipolar Disorder and Borderline Personality Disorder 98
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 98
Personalized medicine with extended-release trazodone and/or once-a-day trazodone: From research trials to clinical practice 96
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications 95
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 94
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 92
Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence 91
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis 90
Rethinking the role of trazodone in the different depressive dimensions 89
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings 88
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine 87
Practical prescribing with COVID-19 medications and psychotropics: a guide to pharmacokinetic interactions 84
Pocket Guide to Practical Psychopharmacology : Lithium and Anticonvulsants in Psychiatric Practice 84
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 82
Prolonged grief disorder in psychiatric patients: Assessing the PG-13-R scale and clinical implications 77
Employment and Social Security/Insurance among patients affected by mental disorders in Italy: A descriptive multi-center study 76
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life" 71
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazine 66
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features 62
Totale 14.927
Categoria #
all - tutte 45.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 0 0 0 0 0 0 0 0 216 73 160
2021/2022751 32 82 57 74 42 40 63 46 82 48 58 127
2022/2023937 55 60 133 86 58 151 29 143 95 44 39 44
2023/20241.378 77 36 96 90 50 284 341 42 18 99 113 132
2024/20253.334 112 146 227 329 366 283 143 141 255 255 347 730
2025/20265.810 546 892 653 785 1.042 294 698 279 252 369 0 0
Totale 14.927